Skip to main content
. 2018 Jan 5;8(1):e017385. doi: 10.1136/bmjopen-2017-017385

Table 1B.

Baseline characteristics of REGARDS participants according to baseline depressive symptoms (CES-D) and self-reported health

Characteristics Self-reported general health as ‘excellent or very good’ Self-reported general health as ‘poor, fair or good’
CES-D<4 (N=12 965) CES-D≥4
(N=725)
P CES-D<4 (N=13 219) CES-D≥4
(N=2523)
P
Sociodemographics
 Age, mean (SD) 64.8 (9.4) 64.5 (10.2) 0.47 65.5 (9.3) 62.8 (9.6) <0.001
 Female, n (%) 6600 (50.9) 501 (69.1) <0.001 7357 (55.7) 1751 (69.4) <0.001
 African-American, n (%) 3726 (28.7) 295 (40.7) <0.001 6677 (50.5) 1404 (55.6) <0.001
 Less than high school education, n (%) 845 (6.5) 119 (16.4) <0.001 2059 (15.6) 658 (26.1) <0.001
 Annual household income, n (%)
  Less than US$20 000 1304 (10.1) 190 (26.2) <0.001 2832 (21.4) 983 (39.0) <0.001
 No health insurance, n (%) 644 (5.0) 70 (9.7) <0.001 884 (6.7) 324 (12.9) <0.001
 Region, n (%) 0.37 <0.001
  Stroke belt* 4282 (33.0) 256 (35.3) 4668 (35.3) 963 (38.2)
  Stroke buckle† 2619 (20.2) 148 (20.4) 2807 (21.2) 601 (23.8)
  Non-stroke belt or buckle 6064 (46.8) 321 (44.3) 5744 (43.5) 959 (38.0)
General health and medical conditions
 Self-reported general health, n (%)
 Poor, fair, good
 Excellent, very good
 CVD, n (%)‡ 1948 (15.0) 144 (19.9) 0.004 3874 (29.3) 840 (33.3) <0.001
 Diabetes, n (%)§ 1443 (11.6) 93 (13.3) 0.16 3840 (30.2) 853 (35.1) <0.001
 COPD, n (%) 796 (6.2) 55 (7.6) 0.11 1507 (11.4) 347 (13.8) 0.007
 Physical component score on SF-12 scale, mean (SD) 52.0 (6.5) 51.3 (9.1) 0.008 42.0 (10.7) 37.7 (11.3) <0.001
Physiological risk factors
 Body mass index, kg/m2, mean (SD) 27.8 (5.1) 28.4 (5.7) 0.006 30.5 (6.6) 31.2 (7.3) <0.001
 Systolic blood pressure, mm Hg, mean (SD) 125.3 (15.7) 126.0 (17.2) 0.27 129.6 (16.9) 129.5 (18.3) 0.91
 Total cholesterol, mg/dL, mean (SD) 193.8 (38.2) 195.5 (38.6) 0.26 189.7 (41.2) 194.4 (44.2) <0.001
 High-density lipoprotein, mg/dL, mean (SD) 53.1 (16.4) 55.8 (16.6) <0.001 50.4 (15.8) 51.5 (16.1) 0.002
 QT interval, corrected for heart rate, ms, mean (SD) 405.6 (22.6) 407.2 (23.5) 0.06 408.7 (24.3) 410.8 (24.2) <0.001
 High-sensitivity C reactive protein, mg/L, median, IQR 1.7 (0.8–3.8) 1.9 (0.9–4.9) 0.004 2.7 (1.2–6.1) 3.4 (1.3–7.7) <0.001
 Albumin to creatinine ratio, mg/g, median, IQR 6.6 (4.3–12.3) 6.9 (4.7–14.0) 0.005 8.4 (5.0–20.7) 8.7 (5.1–22.2) 0.18
Medications
 Antihypertensive medication use, n (%) 4916 (38.3) 297 (41.7) 0.06 8344 (63.9) 1606 (64.5) 0.57
 Statin use, n (%) 3407 (26.4) 176 (24.4) 0.24 4822 (36.5) 870 (34.6) 0.06
 Aspirin use, n (%) 5254 (40.5) 273 (37.7) 0.13 6100 (46.2) 1140 (45.2) 0.36
 Antidepressant use, n (%) 1224 (9.5) 144 (19.9) <0.001 1933 (14.6) 774 (30.8) <0.001
Behavioural risk factors
 Self-reported smoking, pack-years, mean (SD) 11.2 (20.5) 12.1 (21.6) 0.24 15.3 (24.7) 16.5 (25.6) 0.03
 Current smoking, n (%) 1344 (10.4) 114 (15.8) <0.001 2110 (16.0) 684 (27.2) <0.001
 Alcohol use, n (%) 0.01 <0.001
  Heavy 634 (5.0) 38 (5.4) 409 (3.2) 91 (3.7)
  Moderate 5034 (39.4) 238 (33.8) 3746 (29.0) 600 (24.5)
  None 7103 (55.6) 429 (60.9) 8779 (67.9) 1758 (71.8)
 Physical inactivity, n (%) 3107 (24.3) 259 (36.0) <0.001 5372 (41.3) 1242 (50.0) <0.001
 Medication non-adherence, n (%) 2997 (26.2) 211 (33.1) <0.001 3809 (31.0) 926 (39.1) <0.001
  Impaired cognitive status
  (cognitive score ≤4)
587 (5.6) 61 (10.1) <0.001 947 (8.9) 285 (13.3) <0.001
  Elevated perceived stress (PSS ≥5) 2219 (17.1) 404 (55.7) <0.001 4048 (30.6) 1900 (75.3) <0.001

P values from χ2 and Student’s t-tests.

n=total number assuming no missing data.

*Stroke belt defined as the states of Alabama, Arkansas, Louisiana, Mississippi and Tennessee and the non-coastal regions within the states of North Carolina, South Carolina and Georgia.

†Stroke buckle defined as the coastal regions within the states of North Carolina, South Carolina and Georgia.

‡CVD defined as baseline coronary heart disease, stroke, peripheral artery disease or aortic aneurysm.

§Diabetes defined as fasting blood glucose ≥126 or random glucose >200 mL/dL or oral hypoglycaemic or insulin use.

CES-D, Centre for Epidemiology Studies Depression scale; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; PSS, Perceived Stress Scale; REGARDS, Reasons for Geographic and Racial Differences in Stroke; SF-12, Short-Form Health Survey.